⌘K

Login Start Free

Home/Filings/4/0001753926-23-000821

4//SEC Filing

Johnston Douglas 4

Accession 0001753926-23-000821

CIK 0001347242other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:52 PM ET

Size

5.2 KB

Accession

0001753926-23-000821

Insider Transaction Report

Form 4

Period: 2023-06-16

LIPELLA PHARMACEUTICALS INCLIPO

Johnston Douglas

Chief Financial Officer

Transactions

Award
Options to Purchase
2023-06-16+50,000→ 50,000 total
Exercise: $2.19From: 2023-06-16Exp: 2033-06-16→ Common Stock (50,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

LIPELLA PHARMACEUTICALS INC

CIK 0001347242

Entity typeother

Related Parties

1

filerCIK 0001959354

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 4:52 PM ET
Size: 5.2 KB

View on SEC.gov